About us
We’re developing novel biopharmaceutical treatments that target the underlying mechanisms of brain-related conditions to shift the paradigm of neuropsychiatric care. Urgency drives our commitment.
Our Vision
To restore the lives of those with challenging psychiatric and neurological conditions
Our Mission
To create treatments for debilitating brain health disorders by developing transformative biopharmaceuticals to address unmet medical needs
Our Commitment
As a Public Benefit Corporation, we're committed to creating transformative biopharmaceutical treatments for brain-related conditions. In recognition of the traditional knowledge and cultural significance of plant-based medicine, we have established “Healing Forward. Giving Back.” Each year, we will support educational initiatives in collaboration with non-profit organizations working within Indigenous communities to preserve natural resources and foster sustainable growth.
The iboga alkaloids and their uses are investigational and have not been approved by the U.S. Food and Drug Administration (FDA). This information is presented only for the purpose of providing a general overview and should not be construed as a recommendation for use, or FDA approval.